The UK was still in the Brexit transition period last year when it was invited to join the EU’s joint procurement scheme for vaccines. The European Commission would negotiate on behalf of the bloc, which, by virtue of its size, would ensure cheaper prices.
Instead Britain moved alone, first and fast, to secure supplies of the AstraZeneca vaccine – three months before the EU. Which many people who didn’t want Brexit howled about, saying we were Little Englanders, punching above our weight, jeopardising supplies. I remember reading all the articles last summer in the Guardian and The Times.
Prices per dose are confidential, although it is generally accepted that the UK paid more than the EU. Yet the speed at which the UK moved was to prove pivotal.